Suggestions
Michael Chavez
Synthetic Biologist - Grad Student in Stanley Qi's Lab - Fellow at Fifty Years
Michael Chavez is a Ph.D. candidate in Bioengineering at Stanford University, focusing on synthetic biology and immunology. He is part of Professor Stanley Qi's lab, where he specializes in developing novel CRISPR tools for cell-based therapies. His research aims to merge synthetic biology with immunological applications to advance medical technologies, particularly in the fields of cancer immunotherapy and cellular agriculture.12
In addition to his academic pursuits, Michael is the co-founder and CEO of Enoda Cellworks Inc., a company he established to innovate in cell therapy development. His entrepreneurial journey began while he was a graduate student, where he also worked at Fifty Years, a venture capital firm that supports early-stage biotech startups. At Fifty Years, he contributed to biotech diligence and helped create programs that assist researchers in translating their work into commercial products.23
Michael has received several prestigious awards, including the Siebel Scholarship and the National Science Foundation Graduate Research Fellowship. His commitment to using synthetic biology for societal benefit reflects his passion for addressing significant global challenges through scientific innovation.2
Highlights
